4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001567619-19-013840
Director bought 1,388,889 shares at $18.00 ($25,000,002)
- Director acquired 15,397,824 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Harrison Seth Loring · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-21 | Conversion : show line 1 in the form | +4,980,168 | 4,980,168 | I | ||
| 2019-06-21 | Conversion : show line 2 in the form | +7,617,746 | 12,597,914 | I | ||
| 2019-06-21 | Conversion : show line 3 in the form | +2,799,910 | 15,397,824 | I | ||
| 2019-06-21 | Purchase : show line 4 in the form | +1,388,889 | $18.00 | $25,000,002 | 16,786,713 | I |
| Open-market purchases · 1,388,889 sh · avg $18.00 · $25,000,002 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2019-06-21 | Conversion : show line 5 in the form Series A Convertible Preferred Stock | −4,980,168 | 4,980,168 | 0 | I |
| 2019-06-21 | Conversion : show line 6 in the form Series A-2 Convertible Preferred Stock | −7,617,746 | 7,617,746 | 0 | I |
| 2019-06-21 | Conversion : show line 7 in the form Series B Convertible Preferred Stock | −2,799,910 | 2,799,910 | 0 | I |
Loading xslF345X03/doc1.xml…